Respiratory Syncytial Virus Infection

Dear Colleagues,

Respiratory syncytial virus is one of the major causes of acute respiratory viral infection in infants, toddlers and the elderly, being a highly infectious virus and causing a majority of children to contract at least one acute RSV infection by the age of 3. Despite its high burden requiring assessing, especially in low- and low–middle-income countries, RSV surveillance is not wide established. Moreover, the COVID-19 pandemic had a high impact on the seasonality of RSV circulation worldwide, and its current trends along with other respiratory viruses, such as influenza, are to be monitored and described.

The existence of RSV has been known for decades; however, there are still no vaccines approved against it, and the spectrum of antiviral drugs and medications is very limited. The progress accomplished in recent years towards the extensive genetic sequencing of RSV, the development of vaccine candidates against the infection for different age groups as well as studies of potent RSV inhibitors, including novel monoclonal antibodies, have shown promise towards the control of RSV infection, especially in the risk groups.

In this Special Issue, we invite authors to share their latest research on RSV surveillance, epidemiology, genetic divergence, vaccine prevention and therapy. Moreover, this Special Issue is open to submissions for general papers describing RSV as one of the many pathogens causing acute respiratory virus infections.

Dr. Daria Danilenko
Dr. Anna Shtro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.